LRRK2 and Parkinson disease: In the context of neurodegenerative diseases such as Parkinson’s disease, the effects of homotaurine were assessed in 3D neural epithelial stem cell (NESC) organoids derived from iPSCs carrying the LRRK2-G2019S mutation.